UC San Diego First to Test Cancer Drugs in Space Using Private Astronaut Mission
|
Scientists at the UC San Diego, Sanford Stem Cell Institute sent several new experiments to the International Space Station, with the hope of expanding research on human stem cell aging, inflammation, and cancer in low Earth orbit. Read More»
|
|
|
Cross-border Collaboration Between United States and Mexico Improves Survival for Children with Acute Lymphoblastic Leukemia
|
Moores investigator Dr. Paula Aristizabal reports that a cross-border cancer treatment training and access program developed between the United States and Mexico has resulted in a 30% improvement in survival for children with acute lymphoblastic leukemia, which is the most common cancer among children. This international collaboration exhibits an exemplary way to improve cancer care in low or middle income nations. Read More»
|
Joseph Califano Steps Down as Director of Moores Cancer Center
|
Dr. Joseph Califano will resign as Moores Director and return to his roles as Iris and Matthew Strauss Chancellor’s Endowed Chair in Head and Neck Surgery and Director of the Hanna and Mark Gleiberman Head and Neck Cancer Center. Dr. Califano will focus his attention on patient care and his NIH-funded laboratory research on the molecular and biological basis of head and neck cancer. A national search for the next Moores Director is underway, and Dr. Califano will remain Director until a new Director is in place.
|
|
|
June 6, 2023 | 12:00 p.m.
Leichtag Biomedical Research Building, Room 107
|
June 7, 2023 | 12:00 p.m.
Moores Cancer Center, Comer Commons and Zoom
|
June 8, 2023 | 12:00 p.m.
Moores Cancer Center, Comer Commons
|
June 9, 2023 | 12:00 p.m.
Moores Cancer Center, Goldberg Auditorium
|
June 13, 2023 | 12:00 p.m.
Leichtag Biomedical Research Building, Room 107 and Zoom
|
| |
NCI Cancer Prevention Fellowship Program
|
Applications for this postdoctoral fellowship program are open through August 1, 2023.
|
|
Applications for KL2 Mentored Career Development Award Now Open!
|
The ACTRI KL2 award is a mentored career development award that provides up to $120K toward salary, plus benefits, along with $25K per year in research funds. Successful applicants will receive up to 3 years of support. Applications for this program are open through August 15, 2023.
|
|
|
FEATURED FUNDING OPPORTUNITIES |
Cancer Research UK and the National Cancer Institute have released nine new challenges as part of their Cancer Grand Challenges funding opportunities: Ageing and Cancer, Cancer Cell Plasticity, Cancer Inequities, Chemotherapy-induced Neurotoxicities, Early-onset Cancers, Obesity, Physical Activity and Cancer, Retrotransposable Elements, Solid tumors in Children, and T-cell Receptors.
Deadline: Thursday, June 22, 2023
|
This opportunity will provide $100K in direct costs for 3 years. No part of the award may cover institutional overhead or other indirect costs.
Deadline: Tuesday, June 27, 2023
|
This award will support the next generation of creative thinkers with "high-risk/high-reward" ideas that have the potential to improve our understanding of and/or approaches to the prevention, diagnosis, and treatment of cancer. This award will fund early career researchers who have an innovative idea yet lack sufficient preliminary data to obtain traditional funding.
Deadline: Thursday, July 6, 2023
|
This NOSI will enable current NCI grant awardees or cooperative agreement program participants to collaborate with NCI CAP-IT Specialized Centers to support CAP-IT Program research. Collaborations should be proposed by investigators who are not currently CAP-IT Center investigators and whose research scope, interests, and activities, as specified in the parent awards, serve CAP-IT Program research objectives. Potential applicants are encouraged to contact the NCI Program Director to discuss the planned collaboration and application.
Deadline: Thursday, July 6, 2023
|
The Minnesota Ovarian Cancer Alliance will award up to $150,000 in November 2023 to support
research on the early detection of ovarian cancer.
Deadline: Friday, September 1, 2023
|
|
|
Cell
Scott M. Lippman (Cancer Control Program)
|
Immunity
Shane Crotty (Cancer Biology and Signaling) and Ananda W. Goldrath (Hematologic Malignancies)
|
Nature Methods
Lingyan Shi (Solid Tumor Therapeutics)
|
|
|
The CTO Staff Member of the Month for May 2023 is Erika Peterson. Erika's contagious smile and positivity make a world of a difference in patient care. Kudos to Erika for always going above and beyond to help patients everyday.
|
| |
|
COMMUNITY OUTREACH AND ENGAGEMENT |
|
|
June 8, 2023, 5:30 p.m.
Join the San Diego Center for AIDS Research (CFAR) Transgender/Nonbinary Community Advisory Board (TCAB) and Moores Community Outreach and Engagement for the second event in two-part series dedicated to cancer prevention and awareness in the trans and nonbinary community. Led by health providers and developed in collaboration with LGBTQIA+ community members, this series addresses cancer risks, myths, and prevention. The event will be moderated by CFAR TCAB leaders and is open to everyone in the community. Register today.
|
|
|
Manage your preferences | Opt Out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online.
|
3855 Health Sciences Drive MC 0698 | La Jolla, CA 92093 US
|
|
|
This email was sent to sjchristie@ucsd.edu.
To continue receiving our emails, add us to your address book.
|
|
|
|
